From: Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
Number of patients (%), n = 396
Any adverse event
186 (47.0)
Psychotic symptoms
28 (7.1)
Extrapyramidal symptoms
12 (3.0)
Akathisia
8 (2.0)